In-house IP roundup: Charities seek better IP deals; medical device start-ups' patent catch-22; USPTO eligibility guidance creates consistency

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

In-house IP roundup: Charities seek better IP deals; medical device start-ups' patent catch-22; USPTO eligibility guidance creates consistency

Flying money

Managing IP rounds up the latest news and analysis from patent-focused businesses

Piggy

Donation drop pushes medical funders to seek better IP deals

Healthcare charity IP managers say they are negotiating fairer patent commercialisation and management arrangements with universities to replace falling revenue streams and generate cash for new projects. Read more ...




MoneyMedical device start-ups face patent investment catch-22

Fledgling businesses in the medical device sector must spend enormous sums of money developing and protecting their inventions to penetrate the market and attract investment. But they often only have enough start-up money for one of those needs. Read more ...





image1USPTO eligibility guidance could create consistency for tech and life sciences

Barclays, Regeneron, Amadeus and others say the new guidance on Section 101-related subject matter could lead to more reliable patent examinations – and may mark the start of a post-Alice framework reversal. Read more ...







Sign up
 to receive more content like this in Patent Strategy’s weekly newsletter.





more from across site and SHARED ros bottom lb

More from across our site

A decision on a licensing rate payable by Warner Bros and Paramount, and a survey outlining UK businesses’ lack of IP preparation ahead of launching abroad, were among other major talking points
A fresh wave of deals highlights why investors favour IP firms and why independent outfits may soon have to rethink their strategy
King & Spalding has now hired 15 partners from Winston Taylor and legacy firm Winston & Strawn in offices spanning Texas, San Francisco, and Chicago
Firm says its work with a biotech client could signal a sea change in how - and when - law firms enter the drug development process
Evan Lazerowitz, attorney in Robinson + Cole’s bankruptcy and reorganisation group, offers key takeaways for IP interested parties in bankruptcy and insolvency proceedings
While the UK sees heavy IP rankings movement, Germany’s new tiered UPC table signals a shift from early adoption to market maturity
In an exclusive interview, Bernard Ledeboer reveals how a Consolid-backed group of firms wants to expand across Europe, invest in AI and centralise operations to compete at the top tier
Not all private equity firms are the same, so leaders at four externally backed IP firms came together to discuss the frameworks they followed and how they ensured a cultural fit
Top-tier German and Spanish firms are among the advisers on a Europe-wide copyright and licensing tussle concerning the design of the track circuit in Madrid
Partners Alex Wilson and Andreas Kramer say bigger law firm rivals don’t necessarily gain by having a wider jurisdictional reach
Gift this article